Andrew J. Stewart

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Debra E. Levin, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew J. Stewart:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bausch & Lomb Corp Officer Non-Qualified Stock Options (right to purchase) 55,793 $884,877 $15.86 26 Feb 2025 Direct
Bausch & Lomb Corp Officer Common Shares, No Par Value 62,930 $874,097 $13.89 24 Apr 2025 Direct
Bausch & Lomb Corp Officer Common Shares, No Par Value 45,985 $685,177 $14.90 24 Apr 2024 Direct

Insider Reports Filed by Andrew J. Stewart

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BLCO Bausch & Lomb Corp 24 Apr 2025 1 -$54,921 4 Officer 25 Apr 2025, 16:06
BLCO Bausch & Lomb Corp 26 Feb 2025 2 $0 4 Officer 28 Feb 2025, 16:29
BLCO Bausch & Lomb Corp 23 Dec 2024 1 -$45,003 4 Officer 26 Dec 2024, 16:19
BLCO Bausch & Lomb Corp 24 Apr 2024 1 -$58,751 4 Officer 26 Apr 2024, 16:10
BLCO Bausch & Lomb Corp 28 Feb 2024 2 $0 4 Officer 01 Mar 2024, 16:35
BLCO Bausch & Lomb Corp 24 Apr 2023 1 $0 4 The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals. 26 Apr 2023, 17:22
BLCO Bausch & Lomb Corp 24 Apr 2023 0 $0 3 Officer 26 Apr 2023, 17:14